Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
2.850
-0.130 (-4.36%)
Nov 20, 2024, 4:00 PM EST - Market open
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $86.00 million as of November 21, 2024. Its market cap has decreased by -6.32% in one year.
Market Cap
86.00M
Enterprise Value
31.88M
1-Year Change
-6.32%
Ranking
Category
Stock Price
$2.85
Market Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $86.00M, an increase of 51.94%. That is a compound annual growth rate of 4.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 86.00M | -30.98% |
| Dec 29, 2023 | 124.60M | 18.67% |
| Dec 30, 2022 | 105.00M | -73.42% |
| Dec 31, 2021 | 395.00M | -24.17% |
| Dec 31, 2020 | 520.90M | 30.00% |
| Dec 31, 2019 | 400.70M | 1,125.38% |
| Dec 31, 2018 | 32.70M | 247.87% |
| Dec 29, 2017 | 9.40M | -28.24% |
| Dec 30, 2016 | 13.10M | -54.67% |
| Dec 31, 2015 | 28.90M | -48.94% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Invivyd | 91.79M |
| So-Young International | 90.79M |
| Genenta Science | 90.35M |
| Quantum-Si incorporated | 90.34M |
| Allakos | 90.24M |
| Harvard Bioscience | 89.40M |
| WORK Medical Technology Group LTD | 89.01M |
| EDAP TMS | 88.68M |